21-September-2021
Today you can have a look in the insight of team-life in Akceso. We have an internal channel to share the company or personal news and achievements with the entire team – not just via e-mail, but rather directly on our cell phones. It is often happens that we receive news from András Incze (CEO and Founder) like the one on the picture above got today.
Pricing & Reimbursement Pathways
Assessment Of Pricing & Reimbursement Pathways for the product of the client was the topic of the recent project successfully delivered by the Akceso team leading by our expert Sophia Kessabi.
Our client is very satisfied and said:
“I am really pleased with the outcome…. and seldom agree so quickly with [my advisors] recommendations!”
Congrats to the Akceso Team
Congrats to the Akceso Team involved in this project:
- Sophia Kessabi, Advisor, Project Lead
- András Incze, CEO and Fourder
- Chris Shilling, Advisor
We are thankful for our clients to express how satisfied they are. It is not just proves the quality of our work, but motivates us to work harder reaching out to our potential clients and support more and more experts in pharma industry with our services and tools in the area of
- Reimbursement Strategy
- International Reference Pricing
- Pharmaceutical Pricing Strategy
- Market Access
- Managed Entry Agreements
- Launch Sequence Optimization
- and more
for our common goal: for better public health worldwide.
Are you an expert in pharmaceutical industry?
We know, that experts also need trustworthy data for their good decisions and advice to build fruitful strategy.
Contact as for a helping hand and we will support your decision with data from our up-to-date, industry leading database of pharmaceutical prices and reimbursement conditions across portfolios and countries and advise building your strategy with simulations and analyzing pathways.
Read more in our blog
Faces Behind the Tools: Dávid and Szabolcs, Akceso’s Newest Techie Pillars for IRP and MFN Excellence
We are happy to introduce Dávid and Szabolcs, the two newest members of our Techie team, both joined recently in 2025.
Akceso Advisors elects Dr. Seng Chin Mah as Board Member
Akceso Advisors AG, a leading independent global advisory firm specializing in market access, pricing, reimbursement strategy, operations and policy-setting for life-science companies and authorities, announced today the election of Dr. Seng Chin Mah as a new non‑executive member of its Board of Directors.
Mind the communication gap in patient access
Read the story of how the clear communication unlocked the market access potential of an innovative product for our client.
Akceso’s ‘Evidence-based Asset Valuation’ methodology
What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.
